OPGEN
Headquartered in Rockville, Maryland, OpGen (NASDAQ:OPGN) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. OpGen, along with its subsidiaries, Curetis and Ares Genetics, develop and commercialize molecular microbiology solutions to help guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes. Our innovative approaches to infectious disease diagno... stics consist of highly multiplexed syndromic molecular panels, and next-generation sequencing combined with smart bioinformatics and artificial intelligence to address the global threat of antimicrobial resistance (AMR). By integrating these capabilities, we provide unique rapid molecular diagnostic products and services that help to dramatically transform patient care by using precision medicine to guide antibiotic therapy selection and optimize the treatment of life-threatening drug-resistant infections, improve antibiotic stewardship, and decrease the spread of multidrug-resistant microorganisms (MDROs). OpGen Community (Linkedin Group) provides an accessible environment to share information, exchange questions and best practices using OpGen’s technologies in a variety of applications.
OPGEN
Industry:
Biotechnology Genetics Health Care
Founded:
2002-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.opgen.com
Total Employee:
101+
Status:
Active
Contact:
+3018699683
Email Addresses:
[email protected]
Total Funding:
158.73 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Color
Color is a complete platform for healthcare delivery.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-07-14 | AdvanDx | AdvanDx acquired by OpGen | N/A |
Investors List
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Post-IPO Equity - OpGen
Sabby Management
Sabby Management investment in Post-IPO Equity - OpGen
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Post-IPO Equity - OpGen
180 Degree Capital
180 Degree Capital investment in Series C - OpGen
CHL Medical Partners
CHL Medical Partners investment in Series C - OpGen
jVen Capital
jVen Capital investment in Series C - OpGen
Versant Ventures
Versant Ventures investment in Series C - OpGen
Highland Capital Partners
Highland Capital Partners investment in Series C - OpGen
Cross Creek
Cross Creek investment in Series C - OpGen
Mason Wells
Mason Wells investment in Series B - OpGen
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2012-03-22 | BioRelix | OpGen investment in Venture Round - BioRelix | 2.56 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-04 | OpGen Appoints Albert Weber as Chief Financial Officer |
Official Site Inspections
http://www.opgen.com Semrush global rank: 4.52 M Semrush visits lastest month: 2.35 K
- Host name: 49.122.212.35.bc.googleusercontent.com
- IP address: 35.212.122.49
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "OpGen"
About OpGen - diagnostic solutions
Headquartered in Rockville, Maryland, OpGen is a precision medicine company harnessing the power of molecular diagnostics to help combat infectious disease. Our innovative approaches to infectious disease diagnostics consists of highly …See details»
OpGen - Crunchbase Company Profile & Funding
OpGen is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious diseases. OpGen, along with its subsidiaries, Curetis …See details»
Management Team - OpGen
Chief Executive Officer. Full Bio. David E. LazarSee details»
OpGen, Inc. | LinkedIn
OpGen, Inc. | 3,635 followers on LinkedIn. Mission We harness the power of molecular microbiology to develop diagnostic solutions that will optimize the treatment of life-threatening, …See details»
OpGen, Inc. (OPGN) Company Profile & Overview - Stock Analysis
1 day ago OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and …See details»
OpGen, Inc. (OPGN) Company Profile & Facts - Yahoo Finance
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and …See details»
OpGen - The Org
OpGen is uniquely positioned to address the rising antibiotic resistance crisis and is harnessing the power of informatics and genomic analysis to provide complete solutions to protect …See details»
OpGen Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 OpGen has 4 employees across 4 locations and $3.42 m in annual revenue in FY 2023. See insights on OpGen including office locations, competitors, revenue, financials, …See details»
OpGen Inc: Governance, Directors and Executives & Committees ...
Mar 24, 2024 OpGen, Inc. (OpGen) is a precision medicine company using molecular diagnostics and informatics to combat infectious disease. The Company is engaged in …See details»
OpGen CEO and Chairman of the Board Issue Letters to Stockholders
GAITHERSBURG, Md., May 11, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and …See details»
OpGen Reports Third Quarter 2022 Financial Results and Provides ...
Nov 10, 2022 This press release includes statements regarding OpGen’s third quarter 2022 financial results and the current business of OpGen. These statements and other statements …See details»
Board of Directors - OpGen
Chief Executive Officer and Chairman. Full Bio. Christian-Laurent BonteSee details»
OpGen, Inc. (OPGN) Stock Price, News, Quote & History - Yahoo …
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and …See details»
OpGen to Provide Business Update and Financial Results for the …
ROCKVILLE, Md., May 08, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business …See details»
OpGen, Inc. (OPGN) Latest Stock News & Headlines - Yahoo Finance
OpGen Provides Update on Business Operations and Strategic Opportunities. ROCKVILLE, Md., April 29, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the …See details»
News & Media - OpGen
Unyvero. Unyvero Lower Respiratory; Unyvero Urinary Tract; Unyvero System; Unyvero Resources. Product Literature; Publications; Videos; Webinars; Instructions for UseSee details»
OpGen Provides Business Update and Announces Preliminary
Oct 4, 2021 About OpGen, Inc. OpGen, Inc. (Rockville, MD, USA) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat …See details»
OpGen Reports Second Quarter 2022 Financial Results and …
ROCKVILLE, Md., Aug. 11, 2022 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular …See details»
OpGen to Provide Business Update and Financial Results for the …
ROCKVILLE, Md., Oct. 28, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business …See details»